NCT03653884 (AVO) is a clinical trial of Ultrasound monitoring in Obstetric Complication, sponsored by Hôpital NOVO.

Who is sponsoring NCT03653884?

NCT03653884 is sponsored by Hôpital NOVO.

What drugs are being tested in NCT03653884?

Interventions in NCT03653884: Ultrasound monitoring.

What condition does NCT03653884 study?

NCT03653884 studies Obstetric Complication.

Is NCT03653884 still recruiting?

NCT03653884 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT03653884: AVO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intra-abdominal Umbilical Vein Aneurysm

Completed Last updated 19 September 2024

What this trial tests

trial testing Ultrasound monitoring in Obstetric Complication in 43 participants. Completed in 14 September 2021.

Timeline

22 January 2018

Primary endpoint
14 September 2021

14 September 2021

Quick facts

Lead sponsor	Hôpital NOVO
Status	Completed
Study type	OBSERVATIONAL
Enrollment	43
Start date	22 January 2018
Primary completion	14 September 2021
Estimated completion	14 September 2021
Sites	1 location across France

Drugs / interventions tested

Ultrasound monitoring

Conditions studied

Obstetric Complication — all drugs for Obstetric Complication →

Sponsor

Hôpital NOVO — full company profile →

Who can join

Adults 18 to 60, female only, with Obstetric Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the ultrasound characteristics and outcome of pregnancies with fetal Intra-abdominal umbilical vein aneurysm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obstetric Complication

Currently open trials in the same condition.

NCT06728709 — Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients · recruiting
NCT06273007 — Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach · NA · recruiting

Other Hôpital NOVO trials

Trials by the same sponsor.

NCT07394478 — Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica · not yet recruiting
NCT07412340 — Disarticulation Septoplasty Versus Classical Way · not yet recruiting
NCT07298070 — Functional and Aesthetic Outcomes Following Lower Lip Reconstruction · not yet recruiting
NCT07257094 — Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Reha · recruiting
NCT07505706 — Patient Journey in Palliative Care Within the NOVO Hospital Group. · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03653884 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hôpital NOVO
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03653884.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing